WHO ICTRP trial
The effect of androgen on oocyte quality
ChiCTR-OOC-15006497 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-OOC-15006497 |
|---|---|
| Public title | The effect of androgen on oocyte quality |
| Scientific title | The mechanism of androgen regulates oocyte quality through modulation of telomerase activity via Wnt signaling pathway in ovarian granulosa cells |
| Primary sponsor | Shanghai Ninth People's Hospital, Shanghai jiaotong university school of medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | Other |
| Countries | China |
| Conditions | Diminished ovarian reserve |
| Interventions | Basal FSH<10IU/L:No;10=:No;Basal FSH>15IU/L:No |
| Registration date | Jun 3, 2015 |
| Target size | Basal FSH<10IU/L:50;10=:30;Basal FSH>15IU/L:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: